Related content

Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors

By Chandramohan Vidyalakshmi   Mitchell Duane A   Johnson Laura A   Sampson John H   Bigner Darell D  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 977-990

Future Medicine

Access to resources Recommend Favorite

Clinical outcome of immunotherapy with dendritic cell vaccine and cytokineinduced killer cell therapy in hepatobiliary and pancreatic cancer

By              

Molecular and Clinical Oncology, Vol. 4, Iss. 1, 2016-01 ,pp. : 129-133

Science Publishers

Access to resources Recommend Favorite

Dendritic Cell Based Immunotherapy of Cancer with Cell Penetrating Domains

By Batchu Ramesh   Gruzdyn Oksana   Kung Shu   Gruber Scott   Weaver Donald  

Indian Journal of Surgical Oncology, Vol. 5, Iss. 1, 2014-03 ,pp. : 3-4

Springer Publishing Company

Access to resources Recommend Favorite

An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats

By Zhu Xinmei   Lu Chuanzhen   Xiao Baoguo   Qiao Jian   Sun Yi  

Journal of Neuro-Oncology, Vol. 74, Iss. 1, 2005-08 ,pp. : 9-17

Springer Publishing Company

Access to resources Recommend Favorite

Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma

By Waeckerle-Men Ying   Uetz-von Allmen Edith   Fopp Markus   Moos Roger   Böhme Christel   Schmid Hans-Peter   Ackermann Daniel   Cerny Thomas   Ludewig Burkhard   Groettrup Marcus   Gillessen Silke  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 12, 2006-12 ,pp. : 1524-1533

Springer Publishing Company

Access to resources Recommend Favorite